Στερεά Δοσολογική Μορφή: Πλήρης οδηγός για τους τύπους, Διατύπωση & Εφαρμογές
Φεβρουάριος 2, 2026
Scaling a capsule product from lab to commercial production requires systematic checks of formulation, κέλυφος κάψουλας, filling process, ελέγχους κατά τη διαδικασία, packaging and stability, and equipment qualification. Key factors include powder flow properties, fill weight and density, capsule material choice (ζελατίνη εναντίον HPMC), dosing technology and machine settings. A production-scale trial with the actual formulation is essential to confirm performance at target speed and fill weight. Ποιοτικούς ελέγχους (capsule gross/net weight, ακεραιότητα σφραγίδας, IPC charts) and suitable primary packaging (blister vs bottle with moisture/oxygen barriers) safeguard content uniformity and stability. Τελικά, define FAT/IQ/OQ/PQ protocols for the capsule filler, ensuring it meets your specs across speeds and produces consistent batches. Use the checklist below to guide your scale-up and work closely with your capsule-filling equipment supplier to de-risk the transfer to commercial production.
Capsule scale-up is the process of transferring a formulation and filling process from laboratory batches to pilot and full commercial production. It involves verifying that powder blend properties, γεμίστε το βάρος, dosing technology και ρυθμίσεις μηχανής can reliably meet product specifications at larger scale. Οδηγίες FDA (SUPAC-IR) explicitly covers changes like manufacturing scale-up and equipment changes for στερεές από του στόματος δοσολογικές μορφές. Στην πράξη, scale-up means identifying critical process parameters (CPPs) and quality attributes (CQAs) κατά την ανάπτυξη, and then confirming them in pilot and engineering runs before full production.
Key stages include:
Πριν από την πλήρη παραγωγή, review all aspects of your product and process. Συνοπτικά, ensure you:
Each of the above is explained in detail below. After reading, use the Actionable Scale-Up Checklist (at article’s end) to tick off each item.
Powder Flowability: Capsule fill accuracy depends on consistent powder flow. Characterize your blend using multiple metrics — there is no single “flow number”. USP <1174> notes that powder flow is “multifaceted” and requires several tests. Measure bulk/tapped density (to compute Carr’s Index and Hausner Ratio) and simple indices like angle of repose as a first pass. Be alert that fine or cohesive powders may show variable behavior: adhesion and cohesion rise sharply at small particle sizes, and moisture-sensitive powders can cake or stick over time.
Bulk Density and Fill Volume: Always relate capsule weight (mg) to powder volume. Use the formula:
Required powder volume ≈ Target fill weight / Bulk density
Για παράδειγμα, a Size 0 κάψουλα ζελατίνης (≈0.68 mL volume) needs about 0.408 g of a 0.60 g/mL bulk-density powder. If your target fill (π.χ.. 500 mg) exceeds this loose volume, anticipate that tamping pins or dosator compaction will be required. Εν συντομία, calculate the volume versus capsule size for each formulation to ensure a feasible match. (If volume is tight, you may need a larger capsule or a more compactible formulation.)
Μέγεθος Σωματιδίων & Χωρισμός: Check particle size distribution of each component. Very fine particles can cause dusting and poor flow; broad size differences risk blend segregation during handling. Use sieve or laser sizing and verify blend homogeneity. For formulations with a very small (π.χ.. <50 µm) συστατικό, consider granulation or adding glidants.
Υγρασία / Cohesion: Hygroscopic or sticky powders can cling to the hopper or dosing parts. Perform a short humidity stress test: expose a sample to expected processing RH and see if flow changes (κέικ, συσσωμάτωση). If moisture is a concern, plan for dehumidified feed hoppers or anti-static devices. Don’t rely on specs alone; small humidity changes can turn a free-flowing powder into a problematic one.
Confirm on-Target Dose: Make sure you know the exact target fill weight (mg) and desired capsule size. Record these clearly in your development and transfer documents. Bulk density variations between batches can affect the chosen capsule size, so confirm density and fill weight for at least 2–3 representative batches.
Choosing the capsule material and size is a critical scale-up decision. The table below compares ζελατίνη και HPMC σκληρές κάψουλες, the two most common shell types:
| Χαρακτηριστικό | Κάψουλες Ζελατίνης | HPMC (Veggie) Κάψουλες |
| Υλικό | Ζωικό κολλαγόνο (ζελατίνη) | Υδροξυπροπυλομεθυλοκυτταρίνη (cellulose polymer) |
| Typical moisture content | 12–16% | ~4–7% |
| Ευαισθησία στην υγρασία | Sensitive – brittle if too dry, sticky if too wet | More stable – lower shell moisture keeps them less brittle |
| Dissolution speed | Dissolve quickly (traditionally preferred) | Slightly slower than gelatin (lacking protease enzymes) |
| Vegetarian/Allergen status | Not χορτοφάγος (animal) | Vegan/vegetarian-friendly |
| Κόστος | Generally lower cost | Μέτριος (usually higher than gelatin) |
| Θήκες χρήσης | Widely used in pharma; okay for moisture-hardiness? | Preferred for moisture-sensitive or strict veg requirements |
| Regulatory monograph | Hard Gelatin Capsule Shells (USP/NF) | Hard Hypromellose (Vegetable) Capsule Shells (USP/NF) |
| Fill capacity vs. μέγεθος | All sizes available; high fill volume for given size | Similar range; large HPMC capsules are available |
Βασικά Σημεία: Gelatin is traditional and inexpensive, but it absorbs moisture from air and can become brittle or sticky with humidity changes. HPMC capsules contain much less water and are generally better for moisture-sensitive formulations. If your formulation is hygroscopic or moisture-sensitive, HPMC (χορτοφάγος) capsules are often a safer starting point. Από την άλλη πλευρά, if cost is tight and moisture isn’t a problem, gelatin is acceptable for many products. (For special needs, πουλλουλάν or other veggie shells exist – pullulan, για παράδειγμα, has excellent oxygen-barrier properties, but this may be beyond initial scale-up scope.)
Also double-check capsule size vs. γεμίστε το βάρος: sizes 000–5 range from ~1.37 mL down to 0.13 mL. Use your powder’s bulk/tapped density to pick a capsule size that accommodates the full dose without excessive compression. Jinlu's capsule size guide provides capacity charts if needed.
Τελικά, verify shell dimensions and locking mechanism. Capsule suppliers maintain tight tolerances, but it’s good practice to sample and weigh empty shells (καπάκι + σώμα) for consistency. Shell-to-shell weight variation can falsely appear as fill-weight drift. In operations, always use a tare weight or weight-based QC rather than relying on an average shell weight.
Capsule fillers come in different dosing mechanisms. The two main principles are tamping-disc (piston) filling and δοσαρκιστής (σωλήνας) πλήρωση:
Neither system is categorically better. In comparative tests, dosators needed more compactible (συνεκτικός) σκόνες, while tamping-disc fillers were more forgiving to lubricated formulations. When scaling up, match your chosen filling machine’s mechanism to your powder properties: π.χ.. if your blend is very free-flowing, a tamping machine may work well; if it’s sticky or very low-dose, consider a specialized dosator configuration. If switching machines (π.χ.. lab vs plant use different types), expect to re-optimize the formulation or lubrication.
Συμβουλές:
Lab data alone cannot guarantee success at speed. Always run a real formulation trial on the intended capsule filling equipment. Use the actual production blend, target capsule shell and planned fill weight. Schedule time on a production or pilot-scale machine, ideally the model you plan to buy or a representative machine.
Trial steps:
1. Ρύθμιση: Record everything—formulation batch ID, bulk/tapped density, τύπος κάψουλας & μέγεθος, δοσομετρικά μέρη, initial hopper level and machine settings.
2. Low-speed trial: Start at a conservative speed to verify basic feeding: check that capsules separate, γέμισμα, lock properly, and there are no jams or bridging.
3. Normal-speed run: Increase to your planned operating speed (π.χ.. design output rate). Run for a fixed time or count (π.χ.. 1,000 κάψουλες), sampling capsules throughout.
4. High-speed test: Τελικά, test near the machine’s rated top speed (if required by your plan) to see if performance holds.
Measurements: At each speed step, measure at least 10–20 capsules at start, μέση και τέλος. Record gross weight (κάψουλα + κέλυφος) and empty-shell tare separately. Calculate net fill weight and its mean/variance. Note reject (underweight/overweight) counts and types (π.χ.. clear capsules vs dust). Also watch for issues: hopper bridging, powder dust escaping, θραύση κάψουλας, inconsistent locks, και τα λοιπά. All these are recorded in a checklist or log.
Για παράδειγμα, one case study found that simply raising the fill speed on a dosator machine increased vibration, ο οποίος densified the powder bed and significantly changed the average fill weight. Με άλλα λόγια, a short demo at low speed does not guarantee identical behavior at full speed.
Output calculation: Don’t just trust the rated speed (κάψουλες/ώρα) for planning output. Actual hourly output = (ταχύτητα μηχανής) × (availability factor) × (good capsule yield). Expect some downtime (καθάρισμα, hopper refills, απορρίπτει). A simple planning equation is useful:
Effective output (κάψουλες/ώρα) ≈ Rated speed × 0.85 × Yield
(adjust 0.85 as a typical runtime efficiency, and yield as 1 – reject rate).
Use the trial to collect data for that calculation. Για παράδειγμα, if the machine speed is 50,000 καπάκια/ώρα, but you get 2% rejects and 90% χρόνο λειτουργίας, your effective output might be ~44,100 caps/hr. This informs equipment sizing for commercial production.
Implement inline and lab controls to catch issues early during scale-up batches:
Choosing the right primary packaging is essential for commercial capsules:
True shelf life depends on the whole system: σκόνη + κάψουλα + συσκευασία + όροι αποθήκευσης. Once packaging is chosen, prepare ICH stability samples (accelerated and long-term) in that final container-closure. Monitor critical attributes: δραστικότητα, διάλυση, περιεκτικότητα σε υγρασία, capsule integrity and any degradation products. If your product is moisture or oxidation sensitive, test with and without αποξηραντικά or oxygen absorbers to see their impact. Θυμάμαι: the stability expiration date is for the finished product in its container, not the empty capsule shell alone. Stability outcomes may prompt adjustments in packaging (π.χ.. adding desiccant, using foil blisters) or even revisiting the shell material choice.
Before commercial batches, qualify your εξοπλισμός πλήρωσης κάψουλας and establish acceptance criteria:
Engage quality and engineering early. Remember FDA/EU regulations (GMP) expect you to validate and document the entire process. Σύμφωνα με τις οδηγίες του κλάδου, a successful scale-up aligns process parameters and QC protocols from the start so the program “scales without deviation”. Work with your equipment supplier to ensure design and validation plans are on track.
Use the following checklist when preparing for commercial capsule production. Check each item as it’s completed:
| Βήμα & Κατηγορία | Checklist Task |
| Διατύπωση | ☐ Confirm target dose and capsule size (calculate required fill volume) |
| ☐ Measure bulk & tapped densities (compute Carr’s Index, Αναλογία Hausner) | |
| ☐ Test powder flow (γωνία ανάπαυσης, shear cell or rheometry if needed) | |
| ☐ Evaluate particle size distribution and segregation risk | |
| ☐ Check moisture sensitivity / υγροσκοπικότητα (small-scale humidity test) | |
| ☐ Ensure blend homogeneity and API content uniformity | |
| Capsule Shell | ☐ Choose shell material (ζελατίνη, HPMC, και τα λοιπά.) based on moisture and regulatory needs |
| ☐ Confirm capsule dimensions, volume and weight consistency | |
| ☐ Verify capsule locking features and compatibility with fill | |
| ☐ Order and test sample capsules from the approved supplier | |
| Διαδικασία πλήρωσης | ☐ Select dosing mechanism (tamping pins/disc vs dosator) based on formulation properties |
| ☐ Install correct tooling (διαλογέας κάψουλας, filling pins/discs, και τα λοιπά.) | |
| ☐ Set preliminary machine parameters (ταχύτητα, tamp depth, feeder height, και τα λοιπά.) | |
| ☐ Perform pilot runs: start at slow speed, then at planned speed | |
| ☐ Collect fill-weight data (καθαρά & gross) and calculate variability | |
| Machine Trial | ☐ Run full trial with actual formulation and capsule at low, normal and max speeds |
| ☐ Record speed vs output and note any bridging, dust or feed issues | |
| ☐ Calculate actual throughput (καπάκια/ώρα) considering rejects | |
| ☐ Inspect filled capsules for filling, κλείδωμα, και οπτικά ελαττώματα | |
| In-Process QC | ☐ Monitor capsule gross/net weight, fill-weight deviation and trend |
| ☐ Check weight variation against specifications (USP <905> εάν ισχύει) | |
| ☐ Implement capsule inspections (κλείδωμα, χρώμα, βλάβη) | |
| ☐ Conduct preliminary dissolution/content-uniformity tests on pilot samples | |
| Συσκευασία & Σταθερότητα | ☐ Choose primary packaging (φουσκάλα, λωρίδα, or bottle) with proper barrier |
| ☐ Include desiccants or oxygen barriers if needed | |
| ☐ Plan and begin stability testing in final pack (ICH protocols) | |
| ☐ Test prototype batches for shelf-life (υγρασία, υποβιβασμός) | |
| Προσόντα Εξοπλισμού | ☐ Define acceptance criteria (ακρίβεια πλήρωσης, ταχύτητα, ποσοστό απόρριψης, και τα λοιπά.) |
| ☐ Execute FAT on capsule filler with placebo or actual product | |
| ☐ Complete IQ (installation checklists, διαμέτρηση) | |
| ☐ Complete OQ (challenge speed range, συναγερμός, συμπλέξεις) | |
| ☐ Perform PQ (≥3 consecutive batches meeting specs) | |
| Απόδειξη με έγγραφα | ☐ Finalize batch record templates and tech-transfer SOPs |
| ☐ Compile FMEA / risk assessment and validation protocols | |
| ☐ Train operators and QA on process changes and controls |
If you’ve never used this capsule machine or this formulation on that equipment, plan a formal trial. Jinlu recommends: "test the actual formulation on the proposed capsule filling equipment under realistic operating conditions” to avoid surprises. This can be done as part of FAT with the supplier or as a dedicated R&D session. Κατά τη διάρκεια του FAT, insist on using your fill material, κάψουλα, and speed range. Μετά την εγκατάσταση, execute Site Acceptance Testing (ΣΑΤ) then IQ/OQ before any routine production. Engaging the equipment vendor early (for trial runs, custom tooling or software setup) can significantly de-risk the scale-up.
Scale-up is a team sport. Success requires collaboration between development (διατύπωση), μηχανική (εξοπλισμός), quality and production teams. By following this checklist, you ensure no critical factor is missed. The process ultimately leads to συνεπής, high-quality capsules at commercial volumes.
Ready to scale up your capsule production? Jinlu’s experts can support every step—from powder trials to FAT. Επικοινωνήστε μαζί μας to schedule a production-scale test of your formulation on our capsule filling machine. We provide FAT/IQ/OQ services and customized integration to help you reach commercial output smoothly.
Capsule manufacturing scale-up is the process of moving a capsule product from laboratory or pilot batches to commercial production while maintaining consistent formulation performance, γεμίστε το βάρος, ποιότητα του προϊόντος, σταθερότητα, και αποδοτικότητα παραγωγής.
Before scale-up, check powder flowability, χύδην και αξιοποιημένη πυκνότητα, μέγεθος σωματιδίων, ευαισθησία στην υγρασία, capsule shell compatibility, στόχος πλήρωσης βάρους, μέγεθος κάψουλας, filling method, ταχύτητα μηχανής, ελέγχους κατά τη διαδικασία, συσκευασία, σταθερότητα, and validation requirements.
Συχνά ναι, but it should not be assumed automatically. A formulation that works well in a small batch may behave differently at higher production volumes because powder handling, ανάμειξη, δόνηση, συνθήκες σίτισης, υγρότητα, and capsule filling speed can change.
Powder flowability affects how consistently material enters the dosing area of a capsule filler. Poor or unstable flow can cause bridging, inconsistent feeding, παραλλαγή βάρους γεμίσματος, dust generation, and reduced production speed. Flow should therefore be evaluated before commercial-scale filling.
Start with the target dose, powder bulk density, required fill volume, and the filling method. The selected capsule should provide enough usable volume without requiring excessive powder compression. A production-scale filling trial is recommended before the capsule size is finalized.
The choice depends on the formulation, ευαισθησία στην υγρασία, storage environment, regulatory or dietary requirements, and packaging system. Gelatin capsules are widely used, while HPMC capsules are often considered for formulations that require lower shell moisture or plant-based materials.
Higher machine speed can change powder feeding, πυκνότητα κλίνης σκόνης, δόνηση, χρόνος παραμονής, and dosing behavior. Για το λόγο αυτό, stable fill weight at low speed does not automatically prove that the process will remain stable at normal or maximum production speed.
Ναί, especially for cohesive, υγροσκοπικός, χαμηλής πυκνότητας, high-dose, or otherwise difficult formulations. A real machine trial using the actual powder, κέλυφος κάψουλας, στόχος πλήρωσης βάρους, and planned production speed helps verify dosing accuracy, παραγωγή, ποσοστό απόρριψης, and process stability.
Neither format is universally better. Blisters are often selected when individual-dose protection and strong moisture barriers are important, while bottles are efficient for larger counts and high-volume production. The final choice should be based on stability data, απαιτήσεις φραγμού, market needs, and production capacity.
The safest approach is to treat scale-up as a controlled process rather than simply increasing machine speed. Χαρακτηρίστε το σκεύασμα, confirm capsule-shell compatibility, establish filling parameters through trials, monitor fill-weight consistency, verify equipment capacity and make sure downstream packaging can match production output. Document the approved process conditions and investigate deviations before full commercial production.
Αναφορές：
1.Ιδιότητες ρόφησης υγρασίας και εκρόφησης ζελατίνης, HPMC και σκληρές κάψουλες pullulan —— PubMed
2.TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT —— ICH Q12
3.EudraLex – Τόμος 4 – Καλή πρακτική παραγωγής (GMP) κατευθυντήριες γραμμές —— Ευρωπαϊκή Επιτροπή
4.Επιδράσεις των ιδιοτήτων ροής σκόνης στην ομοιομορφία βάρους πλήρωσης κάψουλας —— PubMed
5.Χαρακτηριστικά διάχυσης υγρασίας και διαπερατότητας καψουλών υδροξυπροπυλομεθυλοκυτταρίνης και σκληρής ζελατίνης —— PubMed
6.Επικύρωση διαδικασίας: General Principles and Practices —— FDA
Πέτι Φου, Ιδρυτής της Jinlupacking, φέρνει πάνω 20 χρόνια εμπειρίας στον τομέα των φαρμακευτικών μηχανημάτων. Υπό την ηγεσία του, Η Jinlu έχει εξελιχθεί σε έναν αξιόπιστο προμηθευτή που ενσωματώνει το σχεδιασμό, παραγωγή, και πωλήσεις. Ο Petty είναι παθιασμένος με το να μοιράζεται τις βαθιές του γνώσεις στον κλάδο για να βοηθήσει τους πελάτες να πλοηγηθούν στην πολυπλοκότητα της συσκευασίας φαρμάκων, εξασφαλίζοντας ότι δεν λαμβάνουν μόνο εξοπλισμό, αλλά μια πραγματική συνεργασία ενιαίας εξυπηρέτησης προσαρμοσμένη στους στόχους παραγωγής τους.
